Argenica Therapeutics News and Activities

Argenica Therapeutics is a company listed under the stock ticker AGN (AU).

View the org chart displaying its 8 main executives

Most searched biographies at Argenica Therapeutics

• Liz Dallimore, Director, Chief Executive Officer and Managing Dire...
• Mark Etherton, Director
• Jeannie Joughin, Non-Executive Director

Popular executive movements at Argenica Therapeutics

• Dianne Angus, Non- Executive Chairman of the Board, will leave the company on Dec. 31, 2025  (posted on December 29 2025).
• Terry Budge, Non-Executive Director, is retiring  (posted on November 13 2025).

Create your alert
to follow the executive moves at Argenica Therapeutics.

Argenica Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Argenica Therapeutics

• Argenica Lands $3.97M Tax Rebate, Lifting Cash to $9M Without Dilution
• Argenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug - TipRanks.com
• Here's Why We're Not Too Worried About Argenica Therapeutics' (ASX:AGN) Cash Burn Situation

Social media about Argenica Therapeutics

• Argenica Therapeutics on Wikipedia, Google News & Yahoo Finance
• Argenica Therapeutics on LinkedIn, X (Twitter) & YouTube